Latest Advances

  • Condition: Nonalcoholic Steatohepatitis In Patients With Type 2 Diabetes Mellitus
  • Journal: Digestive diseases and sciences
  • Treatment Used: Empagliflozin
  • Number of Patients: 9
  • Published —
The purpose of the study was to explore whether Empagliflozin added to the usual care for patients with type 2 diabetes mellitus and biopsy-proven nonalcoholic steatohepatitis will benefit nonalcoholic steatohepatitis histology.
Showing 1-1 of 1